Medical device correction: FreeStyle Libre 3 (Abbott – December)

Dec. 2025Pharmacy Updates

Abbott has announced a medical device correction for certain FreeStyle Libre 3 sensors. These sensors monitor blood glucose levels as part of the FreeStyle Libre system, which includes a sensor, reader, and app. The correction applies only to the sensor. No other Libre products or Abbott biowearables are affected.

The sensors are being corrected because some may give incorrect low glucose readings. Individuals with diabetes who get false low readings may make unsafe treatment decisions, such as such as excessive carbohydrate intake or skipping insulin doses. This can pose serious health risks, including injury or death.

The groups below are part of the correction.

  • FreeStyle Libre 3 Sensor
    • Model numbers: 72081-01, 72080-01
    • Unique device identifiers (UDI-DIs): 00357599818005 and 00357599819002
  • FreeStyle Libre 3 Plus Sensor
    • Model numbers: 78768-01, 78769-01
    • UDI-DIs: 00357599844011 and 00357599843014

If a patient’s device’s model number or UDI-DI is listed above, they should visit FreeStyleCheck.com and enter their sensor serial number to learn if their device is affected by the correction. The website explains how to find the serial number.

The FDA recommends that patients with affected sensors stop using them immediately and throw them away. They should then enter their contact information on the website so Abbott can send them a replacement sensor at no cost.

Abbott suggests that those with signs of low glucose or who think their glucose reading is wrong use any glucometer to do a fingerstick test. This includes the built-in blood glucose meter in the FreeStyle Libre 3 reader.

As of Nov. 14, Abbott had reported 736 serious injuries and 7 deaths associated with this issue. The FDA is reviewing this potentially high-risk device issue and will keep the public informed as new information becomes available.

To learn more about this recall, your patients can take one or more of the steps below.

  • Talk to your or their pharmacist.
  • Call Abbott at 1-833-815-4273. Help is available seven days a week from 8 a.m. to 8 p.m. ET.
  • Visit the FDA website.

Recent Announcements

CME Webinar Series: Introducing Physicians and their teams to Value-Based Health Care

Please join us for a new CME-accredited webinar series on value-based care. This series is designed to introduce practicing physicians and their teams to value-based health care. Over the course of six sessions, we will define the components of value and identify the tools necessary to deliver high-value care for a population.
Feb. 2026Education/Webinars

Bridging Smiles and Systems: Collaborative Care for Children with Chronic Conditions

Please join us for a live, CME-accredited and CEU-accredited webinar on May 13 from noon to 1p.m., that will explore the critical connection between oral health and pediatric chronic conditions such as diabetes, asthma, congenital heart disease, and ADHD.
Feb. 2026Education/Webinars

February 2026 UPMC for You and UPMC Community HealthChoices formulary update

Pulmicort Flexhaler has a new distributor, Rubicon Holding. National Drug Codes (NDCs) for Pulmicort Flexhaler from Rubicon Holding are not included in the Medicaid Drug Rebate program and are not covered under the Medicaid Prescription Drug Program. Pulmicort Flexhaler NDCs from the previous manufacturer, H2 Pharma, have been discontinued but may be billed/dispensed until supplies are exhausted.
Feb. 2026Pharmacy Updates